Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This indicates a new administrative refresh of the study record.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record now indicates that results have been posted and includes updated completion dates and related study documents, reflecting the PATHWay trial's final data availability. This update communicates the trial's progression to results reporting and final status to users reviewing the record.SummaryDifference3%

- Check43 days agoChange DetectedThe page revision/version has been incremented from v3.5.2 to v3.5.3, indicating a backend or release update without altering the displayed study information.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no visible changes to study content.SummaryDifference0.1%

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.